The Evolution of Global Immunization: Beyond the Big Catch-Up
The global health community recently reached a pivotal milestone with “The Big Catch-Up.” This historic effort sought to reverse the vaccination declines triggered by the COVID-19 pandemic, successfully reaching an estimated 18.3 million children aged 1 to 5 across 36 countries. By delivering over 100 million doses of life-saving vaccines, the initiative highlighted a critical blueprint for future health interventions.
However, the success of this multi-year effort reveals a deeper truth: whereas massive “catch-up” campaigns are essential for crisis recovery, the long-term survival of millions depends on the resilience of routine immunization systems.
Targeting the “Zero-Dose” Gap
The future of global health is increasingly focused on the “zero-dose” child. These children are often the most vulnerable, living in regions where health infrastructure is weakest. The Big Catch-Up demonstrated that targeted intervention can yield massive results. For instance, 12 countries—including Ethiopia, Kenya, Pakistan, and Zambia—reported reaching more than 60 percent of all zero-dose children under age five.
Ethiopia serves as a primary example of this success, where more than 2.5 million previously zero-dose children received vaccines, alongside nearly 5 million doses of inactivated polio vaccine. The trend moving forward will likely involve deeper integration of these “catch-up” strategies into permanent local health frameworks to ensure no child remains invisible to the healthcare system.
The Shift Toward Routine Immunization Resilience
Despite the wins of targeted campaigns, health agencies are issuing a stark warning: catch-up efforts cannot replace routine immunization. In 2024, an estimated 14.3 million infants globally failed to receive a single vaccine through routine channels. This gap has led to a resurgence of preventable diseases, with measles outbreaks rising in every region and approximately 11 million cases reported in 2024.
The emerging trend is a move toward “immunization resilience.” This means strengthening the day-to-day delivery of vaccines so that pandemics or social disruptions do not lead to millions of missed doses. By focusing on routine programs, health organizations aim to prevent the need for massive catch-up campaigns in the first place.
Expanding the Vaccine Portfolio: HPV and Malaria
Future trends are not just about how vaccines are delivered, but which vaccines are prioritized. We are seeing a strategic expansion into vaccines that target specific demographic burdens, such as cervical cancer and malaria.
In Mozambique, a collaboration between the Government, Gavi, the Vaccine Alliance, UNICEF, and the WHO has protected nearly 3 million girls aged 12–18 with the HPV vaccine. This is critical because cervical cancer is the leading cancer affecting women of reproductive age in Mozambique, claiming an estimated 4,000 lives annually.
Similarly, the focus is shifting toward equitable pricing for new tools. A recent pricing deal for the malaria vaccine, backed by Gavi and executed by UNICEF, is expected to generate up to US$ 90 million in savings for Gavi and participating countries, ensuring that life-saving technology is affordable for the poorest nations.
The Power of Public-Private Partnerships
The architecture of these successes relies on the synergy between multilateral organizations. UNICEF, a founding partner and permanent board member of Gavi, works alongside the WHO to bridge the gap between vaccine development and delivery.
Gavi’s role as a public-private partnership allows it to negotiate bulk prices and reduce commercial risks for manufacturers, making vaccines more accessible to developing countries. This model of “market shaping” is likely to be the dominant trend in how the world handles future health threats and vaccine distribution.
Frequently Asked Questions
What is a “zero-dose” child?
A zero-dose child is a child who has not received any routine vaccinations, leaving them highly vulnerable to preventable diseases.
Why is routine immunization better than catch-up campaigns?
While catch-up campaigns are effective for recovery, routine immunization provides consistent, timely protection that prevents outbreaks from starting and ensures children are protected throughout their early development.
How is the HPV vaccine helping in Mozambique?
The HPV vaccine protects girls against the human papillomavirus, which is the primary cause of cervical cancer—the leading cancer for women of reproductive age in Mozambique.
What do you suppose is the biggest barrier to global vaccine equity? Share your thoughts in the comments below or subscribe to our newsletter for more deep dives into global health trends.
